In the past several years, the United States has struggled to respond to viral outbreaks, such as Ebola and Zika. There is now an awareness of the need to rapidly develop vaccines and treatments for epidemics that can quickly spread from country to country. But questions remain as how to best co
There is a growing push to incorporate patient voices more directly at the FDA in decision making about investigational drugs, but what are the optimal parameters of patients' contributions?
Thursday January 26, 2017
TMEC 227 Mini Amphitheater
260 Longwood Ave
Harvard Medical School
Boston, MA 02115
There has been ongoing debate regarding the ownership of publicly and privately funded trial data. What are the ethical duties to trial participants? What are the possible benefits and harm of rapid widespread data sharing?